步长制药
(603858)
| 流通市值：174.98亿 | | | 总市值：174.98亿 |
| 流通股本：11.06亿 | | | 总股本：11.06亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,013,574,926.59 | 694,130,641.95 | 558,837,302.44 | 2,568,945,765.53 |
| 应收票据及应收账款 | 1,091,253,325.06 | 1,567,514,163.15 | 1,253,825,747.03 | 1,380,695,532.64 |
| 应收账款 | 1,091,253,325.06 | 1,567,514,163.15 | 1,253,825,747.03 | 1,380,695,532.64 |
| 应收款项融资 | 648,040,656.95 | 319,378,140.42 | 110,070,023.65 | 506,761,389.71 |
| 预付款项 | 208,955,525.28 | 138,254,074.67 | 200,544,296.43 | 141,252,470.13 |
| 其他应收款合计 | 195,198,851.85 | 152,160,680.41 | 267,807,809.46 | 297,561,794.51 |
| 存货 | 4,977,895,379.28 | 4,930,359,785.06 | 4,650,944,200.59 | 3,953,153,204.04 |
| 其他流动资产 | 181,285,464.97 | 125,069,918.79 | 131,563,643.76 | 182,715,175.98 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,668,338,664.5 | 8,280,959,838.31 | 7,548,863,515.29 | 9,488,711,940.62 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | 11,359,138.83 | 12,625,602.37 |
| 长期股权投资 | 1,134,221,125.26 | 1,115,872,845.15 | 1,109,814,522.86 | 1,113,767,072.37 |
| 其他权益工具投资 | 380,608,571.71 | 380,608,571.71 | 380,608,571.71 | 343,108,571.71 |
| 投资性房地产 | 229,910,101.04 | 231,444,917.58 | 63,989,062.94 | 64,428,410.22 |
| 固定资产 | 4,728,849,025.86 | 4,728,949,581.03 | 4,804,120,083.14 | 4,884,383,997 |
| 在建工程 | 1,241,737,035.76 | 1,242,708,512.52 | 1,319,696,851.88 | 1,287,566,492.23 |
| 使用权资产 | 24,184,776.59 | 27,996,825.39 | 32,040,947.27 | 36,550,773.88 |
| 无形资产 | 900,843,394.59 | 949,171,339.49 | 990,324,708.3 | 1,034,348,459.04 |
| 开发支出 | 1,428,195,446.14 | 1,376,874,859.72 | 1,254,257,921.27 | 1,199,321,785.12 |
| 商誉 | 1,473,077,772.34 | 1,473,077,772.34 | 2,071,108,541 | 2,071,108,541 |
| 长期待摊费用 | 9,312,314.72 | 9,338,469.65 | 17,476,869.61 | 17,293,714.9 |
| 递延所得税资产 | 376,664,058.29 | 368,191,173.96 | 304,575,002.78 | 295,938,123.75 |
| 其他非流动资产 | 710,474,874.09 | 707,102,835.43 | 710,711,907.68 | 696,364,609.06 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 12,638,078,496.39 | 12,611,337,703.97 | 13,070,084,129.27 | 13,056,806,152.65 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 21,306,417,160.89 | 20,892,297,542.28 | 20,618,947,644.56 | 22,545,518,093.27 |
| 流动负债: | | | | |
| 短期借款 | 226,037,374.99 | 240,116,790.84 | 396,304,670.68 | 499,306,059.56 |
| 应付票据及应付账款 | 2,590,234,573.56 | 2,496,524,265.14 | 1,902,854,720.21 | 2,423,684,633.21 |
| 其中：应付票据 | 130,000,000 | 114,300,000 | 159,000,000 | 295,000,000 |
| 应付账款 | 2,460,234,573.56 | 2,382,224,265.14 | 1,743,854,720.21 | 2,128,684,633.21 |
| 合同负债 | 242,682,513.89 | 237,998,380.13 | 173,237,009.41 | 324,991,359.82 |
| 应付职工薪酬 | 126,796,125.69 | 131,878,876.34 | 94,599,347.65 | 124,105,494.29 |
| 应交税费 | 112,335,458.32 | 186,399,516.05 | 171,358,552.97 | 185,431,777.32 |
| 其他应付款合计 | 2,669,697,631.99 | 2,730,173,570.01 | 2,468,134,349.8 | 3,645,365,820.18 |
| 应付股利 | 40,912,496.02 | 40,912,496.02 | 40,912,496.02 | 1,102,527,998.61 |
| 一年内到期的非流动负债 | 905,226,884.86 | 802,259,376.87 | 505,665,396.32 | 547,792,344.89 |
| 其他流动负债 | 27,959,725.85 | 30,695,091.97 | 22,123,109.79 | 41,772,118.87 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 6,900,970,289.15 | 6,856,045,867.35 | 5,734,277,156.83 | 7,792,449,608.14 |
| 非流动负债: | | | | |
| 长期借款 | 2,548,118,637.89 | 2,097,785,503.89 | 2,250,180,517.89 | 2,222,459,009.13 |
| 租赁负债 | 8,560,099.94 | 11,584,127.95 | 17,560,247.31 | 21,453,455.45 |
| 长期应付款 | 130,000,000 | 143,000,000 | 158,000,000 | 166,000,000 |
| 预计负债 | 5,065,851.32 | 5,065,851.32 | - | - |
| 递延收益 | 307,833,909.33 | 312,286,766.01 | 305,107,784.78 | 313,665,261.12 |
| 递延所得税负债 | 86,188,935.74 | 90,520,052.48 | 91,590,695.5 | 98,006,997.46 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,085,767,434.22 | 2,660,242,301.65 | 2,822,439,245.48 | 2,821,584,723.16 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 9,986,737,723.37 | 9,516,288,169 | 8,556,716,402.31 | 10,614,034,331.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,106,042,645 | 1,106,042,645 | 1,106,042,645 | 1,106,042,645 |
| 资本公积 | 2,493,243,322.31 | 2,493,243,322.31 | 2,493,902,966.13 | 2,493,902,966.13 |
| 减:库存股 | 168,366,598.81 | 1,848,576.51 | - | - |
| 其他综合收益 | 11,632,189.25 | 11,835,812 | 11,598,652.65 | 11,541,237.58 |
| 盈余公积 | 570,790,305 | 570,790,305 | 570,790,305 | 570,790,305 |
| 未分配利润 | 7,550,944,556.96 | 7,436,930,087.49 | 8,043,100,397.54 | 7,864,095,012.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,564,286,419.71 | 11,616,993,595.29 | 12,225,434,966.32 | 12,046,372,166.29 |
| 少数股东权益 | -244,606,982.19 | -240,984,222.01 | -163,203,724.07 | -114,888,404.32 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0.01 |
| 股东权益合计 | 11,319,679,437.52 | 11,376,009,373.28 | 12,062,231,242.25 | 11,931,483,761.98 |
| 负债和股东权益合计 | 21,306,417,160.89 | 20,892,297,542.28 | 20,618,947,644.56 | 22,545,518,093.27 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-28 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |